QCG
PMC

Quadrant Capital Group’s PharMerica Corporation PMC Stock Holding History

Quadrant Capital Group’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-42
Closed -$1K – 2197
2016
Q4 		$1K Sell
42
-3
-7% -$76 ﹤0.01% 1918
2016
Q3 		$1K Hold
45
– – ﹤0.01% 1913
2016
Q2 		$1K Hold
45
– – ﹤0.01% 1897
2016
Q1 		$0 Hold
45
– – ﹤0.01% 2127
2015
Q4 		$1K Hold
45
– – ﹤0.01% 1513
2015
Q3 		$1K Hold
45
– – ﹤0.01% 1154
2015
Q2 		$1K Buy
+45
New +$1.38K ﹤0.01% 1135

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

Quadrant Capital Group's PMC Position: Q1 2017 in Review

Quadrant Capital Group sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 42 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in PMC in Q2 2015 and held it in 7 quarters. The position peaked at $1K in Q4 2016. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

  • Quadrant Capital Group reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
  • Quadrant Capital Group sold 42 PharMerica Corporation shares in Q1 2017, an estimated $1K.
  • Quadrant Capital Group first reported a position in PharMerica Corporation in Q2 2015 and held it in 7 quarters.
  • Quadrant Capital Group's PharMerica Corporation position peaked at $1K in Q4 2016.
  • 152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.